Trial Profile
Memantine for spasticity in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 05 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2010 Results published in Multiple Sclerosis.
- 07 Apr 2008 New trial record.